SCHEMBL6837685

SCHEMBL6837685

FC(F)(F)c1nc2cc(Cl)ccc2c2c1nc(C1CCCCC1)n2CCC1CCNCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.40
NPY1R P25929 2/20 0.37
PIM1 P11309 2/20 0.34
SOS1 Q07889 1/20 0.33
ARF6 P62330 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CNR2 P34972 1/20 0.33
SLC6A4 P31645 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
NOS1 P29475 2/20 0.32
NOS2 P35228 2/20 0.32
TRIM58 Q8NG06 1/20 0.32
BACE1 P56817 1/20 0.31
ACP1 P24666 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
ADORA2A P29274 1/20 0.31
PLAT P00750 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6838584 0.99 ADORA3 (0.39) ADORA3NPY1RPIM1SOS1ARF6
SCHEMBL6833984 0.90 ADORA3 (0.37) ADORA3NPY1RSOS1SLC6A4NOS1
SCHEMBL6833816 0.89 ADORA3 (0.37) ADORA3SOS1ARF6NPC1RAB9A
SCHEMBL6838083 0.89 ADORA3 (0.36) ADORA3NPY1RSOS1CYP2D6SLC6A4
SCHEMBL6837640 0.89 ADORA3 (0.38) ADORA3SOS1ARF6CYP1A2CYP2D6
SCHEMBL6840005 0.88 ADORA3 (0.35) ADORA3NPY1RSOS1ARF6NOS1
SCHEMBL6838003 0.88 ADORA3 (0.37) ADORA3SOS1ARF6CYP1A2CYP2D6
SCHEMBL6833712 0.87 ADORA3 (0.46) ADORA3NPY1RTP53MAPT
SCHEMBL6837810 0.87 ADORA3 (0.37) ADORA3SOS1ARF6SLC6A4ACP1
SCHEMBL6838758 0.86 ADORA3 (0.45) ADORA3NPY1RACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 ADORA3 3201/4885NPY1R 1070/4885PIM1 261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.